Literature DB >> 20303728

Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease.

Irina A Kirpich1, Leila N Gobejishvili, Marjorie Bon Homme, Sabine Waigel, Matt Cave, Gavin Arteel, Shirish S Barve, Craig J McClain, Ion V Deaciuc.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common form of liver disease in the US and refers to a wide spectrum of liver damage, including simple steatosis, steatohepatitis, fibrosis and cirrhosis. The goal of the present study was to achieve a more detailed understanding of the molecular changes in response to high fat-induced liver steatosis through the identification of a differentially expressed liver transcriptome and proteome. Male C57/BL6 mice fed a high-fat lard diet for 8 weeks developed visceral obesity and hepatic steatosis characterized by significantly increased liver and plasma free fatty acid and triglyceride levels and plasma alanine aminotransferase activities. Transcriptome analysis demonstrated that, compared to the control diet (CD), high-fat diet changed the expression of 309 genes (132 up- and 177 down-regulated; by a twofold change and more, P<.05). Multiple genes encoding proteins involved in lipogenesis were down-regulated, whereas genes involved in fatty acid oxidation were up-regulated. Proteomic analysis revealed 12 proteins which were differentially expressed. Of these, glutathione S-transferases mu1 and pi1 and selenium-binding protein 2 were decreased at both the gene and protein levels. This is the first study to perform a parallel transcriptomic and proteomic analysis of diet-induced hepatic steatosis. Several key pathways involving xenobiotic and lipid metabolism, the inflammatory response and cell-cycle control were identified. These pathways provide targets for future mechanistic and therapeutic studies as related to the development and prevention of NAFLD.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303728      PMCID: PMC3860361          DOI: 10.1016/j.jnutbio.2009.11.009

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  57 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma.

Authors:  Rachel E Bullock; Abed M Zaitoun; Guruprasad P Aithal; Stephen D Ryder; Ian J Beckingham; Dileep N Lobo
Journal:  J Hepatol       Date:  2004-10       Impact factor: 25.083

3.  A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease.

Authors:  Zobair M Younossi; Ancha Baranova; Katharine Ziegler; Luca Del Giacco; Karen Schlauch; Timothy L Born; Hazem Elariny; Francesco Gorreta; Amy VanMeter; Abraham Younoszai; Janus P Ong; Zachary Goodman; Vikas Chandhoke
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

4.  Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes.

Authors:  M A Avila; M V Carretero; E N Rodriguez; J M Mato
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

5.  Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model.

Authors:  Sujong Kim; Insuk Sohn; Joon-Ik Ahn; Ki-Hwan Lee; Yeon Sook Lee; Yong Sung Lee
Journal:  Gene       Date:  2004-09-29       Impact factor: 3.688

Review 6.  Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.

Authors:  Enrique Santamaría; Javier Muñoz; Joaquín Fernández-Irigoyen; Jesús Prìeto; Fernando J Corrales
Journal:  Liver Int       Date:  2007-03       Impact factor: 5.828

7.  Changes of the hepatic proteome in hepatitis B-infected mouse model at early stages of fibrosis.

Authors:  Daniela Spano; Flora Cimmino; Mario Capasso; Fulvio D'Angelo; Nicola Zambrano; Luigi Terracciano; Achille Iolascon
Journal:  J Proteome Res       Date:  2008-05-22       Impact factor: 4.466

8.  Proteomic analysis of fructose-induced fatty liver in hamsters.

Authors:  Lihe Zhang; German Perdomo; Dae Hyun Kim; Shen Qu; Steven Ringquist; Massimo Trucco; H Henry Dong
Journal:  Metabolism       Date:  2008-08       Impact factor: 8.694

9.  Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice.

Authors:  Iordanes Karagiannides; Rami Abdou; Aikaterini Tzortzopoulou; Peter J Voshol; Kyriakos E Kypreos
Journal:  FEBS J       Date:  2008-08-27       Impact factor: 5.542

10.  Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A.

Authors:  Lixin Chen; Ying Zeng; Heping Yang; Taunia D Lee; Samuel W French; Fernando J Corrales; Elena R García-Trevijano; Matías A Avila; José M Mato; Shelly C Lu
Journal:  FASEB J       Date:  2004-03-19       Impact factor: 5.191

View more
  61 in total

1.  High-fat but not normal-fat intake of extra virgin olive oil modulates the liver proteome of mice.

Authors:  Isy F de Sousa; Amanda P Pedroso; Iracema S de Andrade; Valter T Boldarine; Alexandre K Tashima; Lila M Oyama; Lillà Lionetti; Eliane B Ribeiro
Journal:  Eur J Nutr       Date:  2020-07-25       Impact factor: 5.614

2.  Binge alcohol-induced microvesicular liver steatosis and injury are associated with down-regulation of hepatic Hdac 1, 7, 9, 10, 11 and up-regulation of Hdac 3.

Authors:  Irina Kirpich; Smita Ghare; Jingwen Zhang; Leila Gobejishvili; Giorgi Kharebava; Swati Joshi Barve; David Barker; Akshata Moghe; Craig J McClain; Shirish Barve
Journal:  Alcohol Clin Exp Res       Date:  2012-02-29       Impact factor: 3.455

Review 3.  Role of xenobiotics in the induction and progression of fatty liver disease.

Authors:  James E Klaunig; Xilin Li; Zemin Wang
Journal:  Toxicol Res (Camb)       Date:  2018-05-18       Impact factor: 3.524

Review 4.  Drug metabolism alterations in nonalcoholic fatty liver disease.

Authors:  Matthew D Merrell; Nathan J Cherrington
Journal:  Drug Metab Rev       Date:  2011-05-25       Impact factor: 4.518

5.  Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease.

Authors:  Irina A Kirpich; Joseph Petrosino; Nadim Ajami; Wenke Feng; Yuhua Wang; Yanlong Liu; Juliane I Beier; Shirish S Barve; Xinmin Yin; Xiaoli Wei; Xiang Zhang; Craig J McClain
Journal:  Am J Pathol       Date:  2016-04       Impact factor: 4.307

6.  Advanced glycation endproduct changes to Bruch's membrane promotes lipoprotein retention by lipoprotein lipase.

Authors:  Marisol Cano; Natalia Fijalkowski; Naoshi Kondo; Sonny Dike; James Handa
Journal:  Am J Pathol       Date:  2011-06-12       Impact factor: 4.307

7.  Dietary Linoleic Acid and Its Oxidized Metabolites Exacerbate Liver Injury Caused by Ethanol via Induction of Hepatic Proinflammatory Response in Mice.

Authors:  Dennis R Warner; Huilin Liu; Matthew E Miller; Christopher E Ramsden; Bin Gao; Ariel E Feldstein; Susanne Schuster; Craig J McClain; Irina A Kirpich
Journal:  Am J Pathol       Date:  2017-10       Impact factor: 4.307

8.  Glutathione S-transferase P deficiency induces glucose intolerance via JNK-dependent enhancement of hepatic gluconeogenesis.

Authors:  Shubha Ghosh Dastidar; Ganapathy Jagatheesan; Petra Haberzettl; Jasmit Shah; Bradford G Hill; Aruni Bhatnagar; Daniel J Conklin
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-08-28       Impact factor: 4.310

9.  Binge ethanol-induced HDAC3 down-regulates Cpt1α expression leading to hepatic steatosis and injury.

Authors:  Irina Kirpich; Jingwen Zhang; Leila Gobejishvili; Giorgi Kharebava; David Barker; Smita Ghare; Swati Joshi-Barve; Craig J McClain; Shirish Barve
Journal:  Alcohol Clin Exp Res       Date:  2013-07-26       Impact factor: 3.455

10.  The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease.

Authors:  Irina A Kirpich; Wenke Feng; Yuhua Wang; Yanlong Liu; David F Barker; Shirish S Barve; Craig J McClain
Journal:  Alcohol Clin Exp Res       Date:  2011-12-07       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.